StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $126 at SunTrust Robinson Humphrey
August 3, 2018 2:32 PM
SunTrust Robinson Humphrey raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $126.00 (from $121.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Stifel Transfers Coverage on BioMarin Pharmaceutical Inc. (BMRN), Maintains Buy
August 6, 2018 4:21 PM
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $120 at Wedbush
August 6, 2018 7:49 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Stifel
August 3, 2018 9:36 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $115 at Morgan Stanley
August 3, 2018 7:43 AM
BioMarin Pharma (BMRN) PT Jumps To $120 On 2 Solid New Growth Drivers - Piper Jaffray
August 3, 2018 7:20 AM
Form 10-Q BIOMARIN PHARMACEUTICAL For: Jun 30
August 3, 2018 6:10 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $98 at Barclays
August 3, 2018 5:06 AM
Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 02
August 2, 2018 4:30 PM
BioMarin Pharma (BMRN) Tops Q2 EPS by 8c, Affirms FY Revenue Guidance, Lowers R&D Expense Guidance
August 2, 2018 4:22 PM
BioMarin Announces Second Quarter 2018 Results
August 2, 2018 4:05 PM
